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Abstract
Background: The population's views concerning influenza vaccine are important in maintaining
high uptake of a vaccine that is required yearly to be effective. Little is also known about the views
of the more vulnerable older population over the age of 74 years.
Methods: A cross-sectional survey of community dwelling people aged 75 years and over wh,
previous participant was conducted using a postal questionnaire. Responses were analysed by
vaccine uptake records and by socio-demographic and medical factors.
Results: 85% of men and 75% of women were vaccinated against influenza in the previous year.
Over 80% reported being influenced by a recommendation by a health care worker. The most
common reason reported for non uptake was good health (44%), or illness considered to be due
to the vaccine (25%). An exploration of the crude associations with socio-economic status
suggested there may be some differences in the population with these two main reasons. 81% of
people reporting good health lived in owner occupied housing with central heating vs. 63% who did
not state this as a reason (p = 0.04), whereas people reporting ill health due to the vaccine was
associated with poorer social circumstances. 11% lived in the least deprived neighbourhood
compared to 36% who did not state this as a reason (p = 0.05) and were less likely to be currently
married than those who did not state this as a reason (25% vs 48% p = 0.05).
Conclusion: Vaccine uptake was high, but non uptake was still noted in 1 in 4 women and 1 in 7
men aged over 74 years. Around 70% reported they would not have the vaccine in the following
year. The divergent reasons for non-uptake, and the positive influence from a health care worker,
suggests further uptake will require education and encouragement from a health care worker
tailored towards the different views for not having influenza vaccination. Non-uptake of influenza
vaccine because people viewed themselves as in good health may explain the modest socio-
economic differentials in influenza vaccine uptake in elderly people noted elsewhere. Reporting of
ill-health due to the vaccine may be associated with a different, poorer background.
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Influenza is a significant cause of winter mortality as well
as acute incapacity in elderly people. Complications are
unpredictable but more common in older adults, who
may need urgent hospitalisation or substantial increases
in home care. The epidemic of 1989 was estimated to
result in about 25,000 additional deaths in England and
Wales, 80% of whom were over the age of 74[1]. Vaccina-
tion is currently the most effective measure against influ-
enza. The use of killed influenza vaccine significantly
reduces morbidity and mortality in elderly people [2-5].
Since 1998 all over 74 year olds in the UK have been
offered influenza vaccination by their general practition-
ers (GPs). This was then extended to all over 64 year olds
in 2000. Influenza vaccine uptake in all over 65 year olds
is monitored with an uptake of 60% achieved in 2000,
and over 70% in subsequent years[6]. Although a number
of previous surveys have suggested non-receipt of vaccina-
tion is linked to a perception the vaccine would make
them ill [7-12] others have suggested non-receipt of vac-
cine uptake in over 64 year olds was also lower in those
who judged their own health to be good[13]. Information
on the prevalence of such a view towards influenza vac-
cine in the UK in the more vulnerable population aged
over 74 years is not known. Such information would help
focus efforts on further improving and maintaining high
uptake in this older age group.
We conducted a cross-sectional postal survey in commu-
nity based over 74 year olds in 2001 soon after eligibility
for influenza vaccine was extended to age 65. We exam-
ined the associations between self perceived health, activ-
ity and influenza vaccine uptake. We also explored
associations between the main reasons for refusing vac-
cine and socio-economic background, an aspect rarely
covered in the literature.
Methods
The subjects were patients aged over 74 years from prac-
tices in the Medical Research Council Trial of Assessment
and Management of Older People in the Community [14]
and who were also taking part in a sub study of influenza
vaccination[15]. In brief the trial was conducted in gen-
eral practice with practices randomised to providing either
universal assessment or targeted assessment of people
aged 75[16]. All participants received a brief multidimen-
sional assessment followed by a nurse-led in-depth assess-
ment in the universal group, whereas in the targeted group
the in-depth assessment was offered only to those with
problems established at the brief assessment. The in-
depth medical assessment included questions on underly-
ing medical conditions and the following socio-economic
information: housing tenure, area of residence based on
the Carstairs deprivation Index[17], population density of
area, smoking status, and marital status. Only participants
in practices in the universal arm of the trial were included
(n = 53 practices) as this arm represented an unselected
sample of all older people aged 75 and over on the prac-
tice lists (apart from people resident in nursing homes or
long stay hospital care who were excluded). The response
rate of individuals to the assessment in the universal arm
was 78%. 34 of the 53 practices in the universal arm also
took part in the flu vaccine study, providing data on influ-
enza vaccine uptake at the individual level. For the survey,
a two stage self-weighted sample (sampling first the prac-
tices, probability proportional to size, and then the indi-
viduals in the practices) was taken such that each patient
had an equal chance of being sampled. Practice lists
updated in 2001 were used and people who had died or
moved away were excluded. Information on influenza
vaccine receipt was obtained from GP records. The ques-
tionnaires were sent from the practice with a letter signed
by the patient's GP after excluding any patients who were
too ill to be approached. Replies were returned to the
research team at LSHTM using prepaid addressed enve-
lopes. It was emphasised that any replies were confiden-
tial and would not be seen by health personnel at the
practice.
The short questionnaire asked respondents whether they
had had influenza vaccination last year. Reasons for hav-
ing or not having influenza vaccination were ascertained
using a list of closed-ended questions together with an
open-ended option. A description of the illness, the vac-
cine and its effectiveness, was then given (figure 1) fol-
lowed by a question on future vaccination intentions.
They were also asked to assess their level of general health
and activity compared to other people of their own age. A
second questionnaire was sent to non-responders after
two weeks. Ethics approval for the survey was obtained
from the then Multi-Centre Research Ethics Committee
(MREC). Return of the completed questionnaire signified
consent.
Influenza vaccine status confirmed by GP records was
used to examine patients' main reasons for having or not
having influenza vaccination. The most common reasons
were examined further in relation to information on
underlying health and socio-economic status collected in
the main trial. All analyses were conducted taking into
account clustering of subjects at the practice level (i.e. the
possible lack of independence of observations in subjects
which may be more correlated than if individuals were
selected at random) by using the svy suit of commands in
Stata 7[18].
The sample size was based on a small survey of elderly
people in 1999 by one of the authors (PM), where 40%
did not have influenza vaccination[19]. The most com-Page 2 of 7
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vaccination (30% or 12% of the whole sample) was that
they did not see themselves as at risk. A sample size of
about 1,270 was aimed for. Based on simple random sam-
pling 111 subjects would have been required to estimate
a 12% prevalence of the perception that they were not at
risk with 6% precision (i.e. a range of 6–18%) with 95%
confidence. This was inflated by four to take into account
clustering at the practice level [20] and increased to take
into account an anticipated response rate of 70%, as seen
in the earlier study. The numbers were then doubled to
allow examination of subgroups, eg in practices that
actively recalled patients for influenza vaccination, if nec-
essary.
Results
Of 1573 patients initially sampled, practice nurses noted
that 67 had died, 121 had moved, and 142 were too ill to
be contacted. Responses to the mailed questionnaire iden-
tified a further 10 who had since died, 24 who had moved
or had wrong addresses and 3 who were too ill to reply.
This left a total of 1206 eligible patients of whom 113
refused and 174 did not reply after a second mailing.
Information on vaccine status in 2000 was missing in
another 35 patients and a further 40 had not completed
the prior full assessment. The effective response rate was
therefore 75% (844/(1206-35-40)).
Of the 844 responders, 85% of 329 men and 75% of 515
women were vaccinated against influenza in 2000 accord-
ing to GP records. This percentage was higher than in the
whole sample (responders and non-responders) where it
was 69.8% and 60.5% in men and women respectively.
However, the age and sex patterns of the responders'
recorded uptake were similar to that of the full sam-
ple[15]. Vaccine recipients were more likely to be male
than female (RR 1.12, 95% CI 1.03–1.22) with a non-sig-
nificant tendency for those aged 80–84 to be more likely
Patient information provided on influenza and influenza vaccinationFigure 1
Patient information provided on influenza and influenza vaccination.
Influenza
Influenza or ‘flu is a cause of colds and ‘flu in winter months. About 
1 in 100 people get ‘flu each year. Some years are worse than 
others.  It can cause fever, chills, headache, cough, sore throat 
and muscle aches.  Although most people are ill for only a few 
days, some have a much more serious illness and may need to go 
into hospital.  Thousands of  people die each year from influenza
related illnesses. Most deaths caused by influenza are in elderly 
people.
There is a vaccine against influenza that is given each year.  The 
viruses that cause influenza change often.  A new influenza 
vaccine is made at the start of each year using viruses that are 
most likely to come to the UK later that year.  If the vaccine 
includes the viruses that are the most common later that year it 
prevents about 6 out of 10 illnesses.  The vaccine does not 
prevent the many other infections that also cause colds and ‘flu
like illnesses.   Occasionally people get mild soreness at the 
injection site and fever and aches for 1-2 days after vaccination.Page 3 of 7
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(1.04, 95% CI 0.9–1.2).
Over 93% of those who stated that they had had influenza
vaccination in the last 12 months also had a GP record of
this. Of those who had a GP record of vaccination last
year, 92% recalled that they had been vaccinated, 4%
thought it was more than a year ago, 2% were not sure and
1% thought the last time they had had influenza vaccine
was a few years ago.
Recall of an invitation or being in a practice that actively
recruited patients (latter information obtained from the
practices) was high for both vaccinated and unvaccinated
patients but was not significantly associated with vaccina-
tion in over 74 year olds in this sample. There was also no
significant association with self-perceived health or inac-
tivity (Table 1).
Reasons given for influenza vaccine receipt
Most vaccinated patients indicated that a reason for being
vaccinated was a recommendation from a health care
worker (Table 2). Recommendation by a health care
worker was defined to include opportunistic offers, face to
face, letter or telephone contacts. A much smaller percent-
age reported recommendation from a friend or relative.
Nearly all those who had had influenza vaccination
agreed either with the statement that prevention was bet-
ter than cure or that they were aware of the benefits, a
quarter perceived themselves at high risk and an even
smaller percentage noted that they had had a bad experi-
ence with influenza in the past
Reasons given for influenza vaccine non-receipt
Of the pre-coded options given the most popular reason
for non receipt of vaccine was that they did not get ill, fol-
lowed by the perception that the vaccine makes them ill or
they lacked interest in influenza vaccination (Table 2).
Fewer than one in ten did not like injections or thought
the vaccine did not work. Perceived allergies to vaccina-
tion were not important.
Of those who had not had the vaccine last year, a substan-
tial percentage reported that they had never had the vac-
cine (30%). A small percentage appeared to lack
knowledge that they needed it each year (6.5%) or did not
know they could have the vaccine (5.3%). A few also vol-
unteered that they thought they were too old for the vac-
cine (5.3%). Information given about influenza, the
vaccine and how effective it is (figure 1) was noted to be
useful in 80% (95%CI 76–84%) of those who had had the
vaccine last year and 45% (35–55%) who had not. Of
those who had not had the vaccine last year, 29% (95% CI
20–40%) said they would have it next season. Of these,
96% said the information was useful compared to 27% of
those who would not have the vaccine next year. Of the
71% who said they would not have the vaccine next year,
the order of importance of attitudes associated with not
having vaccination next year was similar to the whole
group of not vaccinated.
In this sample few reported physical barriers such as lack
of transport, and only one person gave reasons of unsuit-
able surgery times or that the surgery was too far away.
Table 1: Characteristics of patients by vaccination status
Characteristic Not vaccinated n = 169 Vaccinated N = 675 RR adjusted for age, sex 95% CI p value
Number (%) Number (%)
Practice actively recruits patients for 
influenza vaccination
135 (80) 537 (79.6) 1.00 0.88, 1.14 0.98
Patient recalls receiving letter/phone call 
to have vaccine
80 (47) 359 (53) 0.95 0.88, 1.04 0.26
Perception of own health
Excellent 17 (10.3) 48 (7.1) 1
Very good 43 (26.1) 184 (27.4) 1.11 0.95, 1.29
Good 55 (33.3) 231 (34.4) 1.10 0.95, 1.28
Fair 34 (20.6) 174 (25.9) 1.15 0.94, 1.40
Poor 16 (9.7) 34 (5.1) 0.94 0.72, 1.21 0.16
Perception of own activity levels
Very active 27 (16.3) 103 (15.4) 1
Active 76 (45.8) 334 (49.8) 1.03 0.97, 1.16
Not very active 34 (20.5) 175 (26.1) 1.07 0.93, 1.22
Not active 29 (17.5) 58 (8.7) 0.87 0.67, 1.12 0.07Page 4 of 7
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The crude association between the two main reasons
against influenza vaccination and socio-economic status
as well as underlying health were explored (table 3). A
statement that they were generally healthy was associated
with living in owner occupied housing with central heat-
ing, not living in urban areas and not having a history of
past influenza. There was also a non significant associa-
tion with being non-smokers. People who reported that
they did not have the vaccine because it might make them
ill were less likely to be currently married, and less likely
to live in comfortable neighbourhoods.
Discussion
Influenza vaccine uptake in 75 year olds and older did not
appear to be related to perception of their health or activ-
ity levels. Of those who had not had the vaccine 70%
Table 3: Characteristics of people with the two most common reasons for not having influenza vaccine
Characteristic Stated did not get ill vs rest 
(n = 50/107)
Stated might make them ill vs rest
(n = 28/107)
Married 52 vs 33% p = 0.15 25 vs 48% p = 0.032
Urban residence 10 vs 25% p = 0.007 14 vs 19% p = 0.66
Never smoked 48 vs 35% p = 0.2 39 vs 42% p = 0.86
Least deprived neighbourhood 22 vs 30% p = 0.29 11 vs 32% p = 0.049
Owner occupied with central heating 81 vs 63% p = 0.037 71 vs 74% p = 0.65
Had experience of flu 38 vs 75% p = 0.0004 71 vs 53% p = 0.12
Respiratory illness 58 vs 46% p = 0.33 36 vs 57% p = 0.18
Cardiovascular illness 88 vs 81% p = 0.18 11 vs 18% p = 0.31
Table 2: Patients' reasons for having or not having influenza vaccination
N % 95% CI
Reasons for having vaccine (N = 675)
Positive attitude to prevention1 588 87.1 84.4 89.8
Recommended by HCW 559 82.8 78.1 86.7
Recommended by friend/relative 73 10.8 9.2 12.7
Perceived themselves at higher risk because of an underlying medical condition 166 24.6 21.7 27.9
Perceived bad past experience with influenza 120 17.8 15.2 20.8
Reasons for not having vaccine (N = 169)
Attitudes to vaccination
Don't get ill 75 44.4 37.4 51.9
Perception vaccine makes them ill 43 25.4 18.1 32.8
Not interested 28 16.6 11.6 22.3
Do not like injections 19 11.2 7.1 17.9
Perception would not work 21 12.3 8.1 19.3
Allergy to vaccine 9 5.3 3.3 8.8
Did not get around to it 9 5.3 3.0 9.5
Knowledge
Never had it before 51 30.2 22.2 38.1
Did not know needed each year 11 6.5 3.3 10.8
Volunteered thought they were too old 9 5.3 2.1 8.4
Did not know could have it 5 5.3 1.2 7.2
Physical barriers
No transport 11 6.5 3.8 11.3
Unable to attend because of ill health 9 5.3 2.6 11.1
Time of clinics not suitable 1 0.6 0.1 4.5
Too far away 1 0.6 0.1 4.5
1Agreed they were aware of benefits or prevention better than curePage 5 of 7
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year. The commonest reasons for not having had influ-
enza vaccination in this population of over 74 year olds
was that they judged their own health to be good. A
smaller percentage thought the vaccine could make them
ill.
The differences in some socio-demographic factors associ-
ated with these two reasons for not having influenza vac-
cination suggest that the perceptions are distinct in the
way they evolve. It appears that people who felt they did
not need influenza vaccine because they had excellent
health were likely to be better supported in terms of mar-
ital status and socio-economic status. In contrast peoples'
perceptions that the vaccine makes them ill were associ-
ated with poorer social circumstances. The lack of uptake
of influenza vaccine for differing reasons by people with
different material backgrounds may explain why the
socio-economic differentials in influenza vaccine uptake
noted elsewhere are modest[15].
In the survey, self report of influenza vaccine was con-
firmed in patient medical records in the great majority.
Over 93% of peoples' recalls of influenza vaccination
were verified by health centre records confirming that
influenza vaccination, as reported by patients, is highly
reliable. The same level of reliability was seen in a study of
over 64 year olds in Finland[9] and in a different study of
over 64 year olds in the UK[21].
The attitudes to past vaccination seen here were related
similarly to future intentions re influenza vaccination.
Although we were not able to test their predictive value,
others have noted a clear relationship between intention
and actual uptake of influenza vaccine[22].
The respondents to the postal survey were people who
may be less typical than the general population of over 74
year olds because they were willing to take part in this sur-
vey. They were also more likely to be vaccinated than
those who did not complete a questionnaire so that the
prevalence of negative attitudes to influenza vaccination is
likely to be underestimated compared to the prevalence in
the general population. It is also possible that the associ-
ation between non-receipt of vaccination and less favour-
able socioeconomic circumstances is under-estimated.
The high percentage who accepted uptake associated with
a recommendation by a health care worker is consistent
with other studies [9,11,23] especially among those who
have not had previous vaccination [24].
Studies in other settings have also shown that thinking
that the vaccine makes them ill was associated with non-
receipt of vaccination [7-12], Our findings in over 74 year
olds mirrors that of the Dutch study of over 64 year olds
which showed that receipt of vaccine uptake was lower in
those who judged their own health to be good[13] Our
findings are also consistent with results from qualitative
interviews of people over 74 years of age in the UK. The
decision to be vaccinated against influenza was thought to
be based on beliefs about whether it would prevent colds
and influenza or cause colds and influenza and not on
whether they saw themselves as at high risk. Of interest is
that those with positive views of influenza vaccine saw
any post vaccine ill health either as coincidence or were
happy to continue with professional advice[25].
In Sweden and the US influenza vaccine uptake is higher
in those with higher levels of education[26,27], however,
a Canadian telephone survey did not find uptake to be sig-
nificantly related to education[8]. They also saw no differ-
ence in uptake according to household income. This
difference in findings maybe because of a greater effort by
health care workers to promote vaccination in Canada.
We were not able to look at education levels. We instead
explored the links between perceptions of influenza vac-
cine and social and health related backgrounds and sug-
gest that, underlying the documented socio-economic
differentials in influenza vaccine uptake [15,28], there are
divergent attitudes.
A belief that the vaccine can make one ill appears be asso-
ciated with socio-demographic patterns consistent with
reduced access or ability to act upon accurate knowledge.
People who think they do not need the vaccine because
they are generally healthy appear to have good social sup-
port in terms of being currently married and there is some
indication of more healthy behaviours. Education at older
ages would be reasonably expected to reduce both beliefs
that the vaccine lacks effect or that it gives rise to illness.
Conclusion
Health workers have a positive influence on influenza vac-
cine uptake and should continue to try to advise people
and give individual education to all who refuse influenza
vaccine, not just those who think the vaccine might make
them ill. An important message for all those who decline
influenza vaccine is the ability for even seasonal influenza
to change from year to one where there maybe little pro-
tective immunity in the population
This work also provides an initial insight into the possible
backgrounds in which particular perceptions of influenza
vaccine might occur and needs to be confirmed elsewhere.
Changes in the prevalence of such perceptions and associ-
ations with socio-economic status as a result of increasing
experience of the health service offering vaccination
against seasonal influenza each year as well as worries
over an influenza pandemic would also be of interest.Page 6 of 7
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